Kentucky Retirement Systems Insurance Trust Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kentucky Retirement Systems Insurance Trust Fund’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283K	Hold	5,003	–	–	0.02%	476
2025 Q4	$297K	Hold	5,003	–	–	0.02%	477
2025 Q3	$271K	Sell	5,003 -131	-3%	-$7.49K	0.02%	484
2025 Q2	$282K	Sell	5,134 -356	-6%	-$21K	0.02%	474
2025 Q1	$388K	Buy	+5,490	New	+$369K	0.03%	454

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kentucky Retirement Systems Insurance Trust Fund's BMRN Position: Q1 2026 in Review

Kentucky Retirement Systems Insurance Trust Fund held its BioMarin Pharmaceuticals (BMRN) position steady in Q1 2026 at 5,003 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #476.

Kentucky Retirement Systems Insurance Trust Fund first reported a position in BMRN in Q1 2025 and has held it in 5 quarters since. The position peaked at $388K in Q1 2025. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Kentucky Retirement Systems Insurance Trust Fund held 5,003 shares of BioMarin Pharmaceuticals worth $283K as of Q1 2026.
Kentucky Retirement Systems Insurance Trust Fund left its BioMarin Pharmaceuticals share count unchanged in Q1 2026.
BioMarin Pharmaceuticals made up 0.02% of Kentucky Retirement Systems Insurance Trust Fund's portfolio in Q1 2026, its #476 holding.
Kentucky Retirement Systems Insurance Trust Fund first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Kentucky Retirement Systems Insurance Trust Fund's BioMarin Pharmaceuticals position peaked at $388K in Q1 2025.
555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q1 2026, filed 19 May 2026.